Page last updated: 2024-10-31

mexiletine and Deafness

mexiletine has been researched along with Deafness in 1 studies

Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.

Deafness: A general term for the complete loss of the ability to hear from both ears.

Research Excerpts

ExcerptRelevanceReference
"In 5 Mexiletine was added, shortening QTc and obtaining the disappearance of the T-wave alternance (TWA) in 3/3."1.91Autosomal Recessive Long QT Syndrome: Clinical Aspects and Therapy. ( Baban, A; Di Mambro, C; Drago, F; Gnazzo, M; Novelli, A; Paglia, S; Porco, L; Righi, D; Silvetti, MS; Tozzi, AE, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Righi, D1
Porco, L1
Di Mambro, C1
Gnazzo, M1
Baban, A1
Paglia, S1
Silvetti, MS1
Novelli, A1
Tozzi, AE1
Drago, F1

Other Studies

1 other study available for mexiletine and Deafness

ArticleYear
Autosomal Recessive Long QT Syndrome: Clinical Aspects and Therapy.
    Pediatric cardiology, 2023, Volume: 44, Issue:8

    Topics: Child; Deafness; Heart Arrest; Humans; Jervell-Lange Nielsen Syndrome; KCNQ1 Potassium Channel; Long

2023